ARCHIVES

FDA Lists Therapies being Tested For AIDS, Opportunistic Infections

This article is from The Cancer Letter archive.

Vol. 18 No. 04 | January 24, 1992

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 4 Issue 3, Summer 1990

June 13, 1990

Tobacco Council awards $10 Million In 1986

August 14, 1987

Niederhuber Leads AACI

November 2, 2001

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

January 7, 2005

In the States: Arizona Approves Legislation on Patient Care Costs in Trials

May 5, 2000

Bishop: Scientists Need Seat At NCI Executive Committee, More Voice In Decision Making

February 24, 1995